Literature DB >> 18840448

Zinc binding modulates the entire folding free energy surface of human Cu,Zn superoxide dismutase.

Can Kayatekin1, Jill A Zitzewitz, C Robert Matthews.   

Abstract

Over 100 amino acid replacements in human Cu,Zn superoxide dismutase (SOD) are known to cause amyotrophic lateral sclerosis, a gain-of-function neurodegenerative disease that destroys motor neurons. Supposing that aggregates of partially folded states are primarily responsible for toxicity, we determined the role of the structurally important zinc ion in defining the folding free energy surface of dimeric SOD by comparing the thermodynamic and kinetic folding properties of the zinc-free and zinc-bound forms of the protein. The presence of zinc was found to decrease the free energies of a peptide model of the unfolded monomer, a stable variant of the folded monomeric intermediate, and the folded dimeric species. The unfolded state binds zinc weakly with a micromolar dissociation constant, and the folded monomeric intermediate and the native dimeric form both bind zinc tightly, with subnanomolar dissociation constants. Coupled with the strong driving force for the subunit association reaction, the shift in the populations toward more well-folded states in the presence of zinc decreases the steady-state populations of higher-energy states in SOD under expected in vivo zinc concentrations (approximately nanomolar). The significant decrease in the population of partially folded states is expected to diminish their potential for aggregation and account for the known protective effect of zinc. The approximately 100-fold increase in the rate of folding of SOD in the presence of micromolar concentrations of zinc demonstrates a significant role for a preorganized zinc-binding loop in the transition-state ensemble for the rate-limiting monomer folding reaction in this beta-barrel protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18840448      PMCID: PMC2756654          DOI: 10.1016/j.jmb.2008.09.045

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  59 in total

1.  Impaired post-translational folding of familial ALS-linked Cu, Zn superoxide dismutase mutants.

Authors:  Cami K Bruns; Ron R Kopito
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

2.  Binding of a single zinc ion to one subunit of copper-zinc superoxide dismutase apoprotein substantially influences the structure and stability of the entire homodimeric protein.

Authors:  Soshanna Zittin Potter; Haining Zhu; Bryan Francis Shaw; Jorge A Rodriguez; Peter A Doucette; Se Hui Sohn; Armando Durazo; Kym F Faull; Edith Butler Gralla; Aram M Nersissian; Joan Selverstone Valentine
Journal:  J Am Chem Soc       Date:  2007-03-24       Impact factor: 15.419

Review 3.  Zinc and brain injury.

Authors:  D W Choi; J Y Koh
Journal:  Annu Rev Neurosci       Date:  1998       Impact factor: 12.449

4.  The metal binding properties of the zinc site of yeast copper-zinc superoxide dismutase: implications for amyotrophic lateral sclerosis.

Authors:  T J Lyons; A Nersissian; H Huang; H Yeom; C R Nishida; J A Graden; E B Gralla; J S Valentine
Journal:  J Biol Inorg Chem       Date:  2000-04       Impact factor: 3.358

5.  The coupling between disulphide status, metallation and dimer interface strength in Cu/Zn superoxide dismutase.

Authors:  Andreas Hörnberg; Derek T Logan; Stefan L Marklund; Mikael Oliveberg
Journal:  J Mol Biol       Date:  2006-09-23       Impact factor: 5.469

Review 6.  Folding versus aggregation: polypeptide conformations on competing pathways.

Authors:  Thomas R Jahn; Sheena E Radford
Journal:  Arch Biochem Biophys       Date:  2007-06-08       Impact factor: 4.013

7.  Denaturational stress induces formation of zinc-deficient monomers of Cu,Zn superoxide dismutase: implications for pathogenesis in amyotrophic lateral sclerosis.

Authors:  Vikram Khipple Mulligan; Aaron Kerman; Sylvia Ho; Avijit Chakrabartty
Journal:  J Mol Biol       Date:  2008-08-22       Impact factor: 5.469

8.  Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS.

Authors:  Lucia Banci; Ivano Bertini; Armando Durazo; Stefania Girotto; Edith Butler Gralla; Manuele Martinelli; Joan Selverstone Valentine; Miguela Vieru; Julian P Whitelegge
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

9.  Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS.

Authors:  Blaine R Roberts; John A Tainer; Elizabeth D Getzoff; Dean A Malencik; Sonia R Anderson; Valerie C Bomben; Kathrin R Meyers; P Andrew Karplus; Joseph S Beckman
Journal:  J Mol Biol       Date:  2007-08-02       Impact factor: 5.469

10.  Structures of the G85R variant of SOD1 in familial amyotrophic lateral sclerosis.

Authors:  Xiaohang Cao; Svetlana V Antonyuk; Sai V Seetharaman; Lisa J Whitson; Alexander B Taylor; Stephen P Holloway; Richard W Strange; Peter A Doucette; Joan Selverstone Valentine; Ashutosh Tiwari; Lawrence J Hayward; Shelby Padua; Jeffrey A Cohlberg; S Samar Hasnain; P John Hart
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

View more
  30 in total

1.  The role of solvent exclusion in the interaction between D124 and the metal site in SOD1: implications for ALS.

Authors:  Raúl Mera-Adasme; Carl-Mikael Suomivuori; Angélica Fierro; Janne Pesonen; Dage Sundholm
Journal:  J Biol Inorg Chem       Date:  2013-09-13       Impact factor: 3.358

2.  The Disulfide Bond, but Not Zinc or Dimerization, Controls Initiation and Seeded Growth in Amyotrophic Lateral Sclerosis-linked Cu,Zn Superoxide Dismutase (SOD1) Fibrillation.

Authors:  Madhuri Chattopadhyay; Ekeoma Nwadibia; Cynthia D Strong; Edith Butler Gralla; Joan Selverstone Valentine; Julian P Whitelegge
Journal:  J Biol Chem       Date:  2015-10-28       Impact factor: 5.157

3.  Insights into SOD1-linked amyotrophic lateral sclerosis from NMR studies of Ni(2+)- and other metal-ion-substituted wild-type copper-zinc superoxide dismutases.

Authors:  Li-June Ming; Joan Selverstone Valentine
Journal:  J Biol Inorg Chem       Date:  2014-04-02       Impact factor: 3.358

4.  Cutting off functional loops from homodimeric enzyme superoxide dismutase 1 (SOD1) leaves monomeric β-barrels.

Authors:  Jens Danielsson; Martin Kurnik; Lisa Lang; Mikael Oliveberg
Journal:  J Biol Chem       Date:  2011-06-23       Impact factor: 5.157

5.  Disulfide-reduced ALS variants of Cu, Zn superoxide dismutase exhibit increased populations of unfolded species.

Authors:  Can Kayatekin; Jill A Zitzewitz; C Robert Matthews
Journal:  J Mol Biol       Date:  2010-02-23       Impact factor: 5.469

6.  Enthalpic barriers dominate the folding and unfolding of the human Cu, Zn superoxide dismutase monomer.

Authors:  Can Kayatekin; Noah R Cohen; C Robert Matthews
Journal:  J Mol Biol       Date:  2012-09-18       Impact factor: 5.469

7.  Measuring copper and zinc superoxide dismutase from spinal cord tissue using electrospray mass spectrometry.

Authors:  Timothy W Rhoads; Nathan I Lopez; Daniel R Zollinger; Jeffrey T Morré; Brian L Arbogast; Claudia S Maier; Linda DeNoyer; Joseph S Beckman
Journal:  Anal Biochem       Date:  2011-03-29       Impact factor: 3.365

8.  Metal-free ALS variants of dimeric human Cu,Zn-superoxide dismutase have enhanced populations of monomeric species.

Authors:  Anna-Karin E Svensson; Osman Bilsel; Can Kayatekin; Jessica A Adefusika; Jill A Zitzewitz; C Robert Matthews
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

9.  Composition of soluble misfolded superoxide dismutase-1 in murine models of amyotrophic lateral sclerosis.

Authors:  Per Zetterström; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Stefan L Marklund
Journal:  Neuromolecular Med       Date:  2012-10-18       Impact factor: 3.843

10.  Functional features cause misfolding of the ALS-provoking enzyme SOD1.

Authors:  Anna Nordlund; Lina Leinartaite; Kadhirvel Saraboji; Christopher Aisenbrey; Gerhard Gröbner; Per Zetterström; Jens Danielsson; Derek T Logan; Mikael Oliveberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.